Pharmaceutical Formulation Scientists are integral to the drug development process, specializing in creating drug products that are both effective and safe for patient use. They focus on transforming active pharmaceutical ingredients (APIs) into practical, stable, and reliable dosage forms, such as tablets, capsules, injectables, or topical creams. Their expertise involves understanding the physicochemical properties of both the drug and excipients to design formulations that optimize bioavailability, stability, and controlled release. This is essential to ensuring that the drug performs as intended once administered to the patient, maintaining therapeutic efficacy over its shelf life. Their work is vital to the development of new therapies, ensuring that the drug product remains consistent and effective across all stages of production and usage.
These scientists work collaboratively with teams from various disciplines, including regulatory affairs, analytical chemistry, and manufacturing, to develop formulations that meet rigorous safety and quality standards. They are responsible for conducting pre-formulation studies, stability testing, and compatibility studies to determine the best formulation strategies for a given drug. Furthermore, they also play a critical role in scaling up drug production, ensuring that formulations maintain their quality at large manufacturing volumes. As the pharmaceutical landscape evolves, pharmaceutical formulation scientists are at the forefront of developing innovative drug delivery systems, including biologics, vaccines, and personalized medicines, ultimately improving patient care and the success of new therapeutic products.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India